STEMCELL-TECHNOLOGIES
19.1.2024 17:11:30 CET | Business Wire | Press release
STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the acquisition of Propagenix Inc.—a Maryland-based biotechnology company focused on developing technologies to enable new approaches in regenerative medicine.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240119648511/en/
STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the acquisition of Propagenix Inc.—a Maryland-based biotechnology company focused on developing technologies to enable new approaches in regenerative medicine. (Pictured: STEMCELL's headquarters in Vancouver, BC) (Photo: Business Wire)
“The acquisition of Propagenix is an important step in STEMCELL’s growth journey and an achievement for Canada's biotechnology industry,” said Dr. Allen Eaves, President and CEO, STEMCELL. “Propagenix’s technology has the potential to contribute to big advancements in scientific research in both labs and clinical settings for the treatment of cancer, airway diseases, and other disorders, and we are thrilled to welcome its portfolio into STEMCELL’s product suite.”
Founded in 2014, Propagenix has developed and commercialized unique technologies, including its patented EpiX™ technology. In 2017, STEMCELL licensed the rights to EpiX™ for research use applications. This technology has the potential to address clinical needs in replacing a patient’s own damaged barrier tissues, like skin and intestinal tissue, with engineered tissue solutions. The current acquisition now enables STEMCELL to develop products based on EpiX™ technology for clinical applications.
“We are delighted that the amazing team of scientists at STEMCELL will ensure Propagenix technologies and capabilities for epithelial cell biology are deployed to their fullest to serve the life science research community,” said Dr. Brian Pollok on behalf of Propagenix co-founders.
STEMCELL’s acquisition includes all of Propagenix’s assets and intellectual property portfolio, its existing business arrangements, as well as its exclusive license to Conditional Reprogramming technology with Georgetown University. Conditional Reprogramming allows scientists to grow tumors and healthy tissue in laboratory settings for research and has potential applications for regenerative medicine and drug screening for personalized medicine.
“With Propagenix’s technology, STEMCELL looks forward to supporting scientists who are advancing research and developing clinical applications to ultimately create better health outcomes for patients being treated for certain diseases,” said Dr. Eaves.
About STEMCELL Technologies
STEMCELL Technologies supports life sciences research with more than 2,500 specialized reagents, tools, and services. STEMCELL offers high-quality cell culture media, cell separation technologies, instruments, accessory products, educational resources, and contract assay services that are used by scientists performing stem cell, immunology, cancer, regenerative medicine, and cellular therapy research globally.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240119648511/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Lenovo Technology Powers FIFA World Cup 2026™ Operations and Strengthens AI-Driven Broadcast2.6.2026 15:00:00 CEST | Press release
Lenovo’s Near Real-Time AI Infrastructure Enables IPTV Delivery, Operational Control, and Transformative Fan Experiences at Unprecedented Global Scale Lenovo today announced it is delivering a near real-time AI-powered infrastructure platform for the FIFA World Cup 2026™ to enable ultra-low-latency IPTV (Internet Protocol Television) video distribution in addition to the traditional cable and satellite broadcast, intelligent content delivery, and mission-critical decision-making across the event ecosystem and operations. As the world’s largest sporting event prepares for an unprecedented scale—spanning three host countries, featuring 48 teams, and engaging an estimated 6 billion fans—FIFA, broadcasters, and event operators will benefit from a live, always-on environment designed to perform at the highest level. As FIFA’s Official Technology Partner, Lenovo will deploy servers at the International Broadcast Center in Dallas, Texas, to help deliver the computing power, devices, and AI-dr
High Q Technologies and Creative Biostructure Announce Strategic Partnership Expanding Global Access to Quantum-Enabled EPR Spectroscopy2.6.2026 15:00:00 CEST | Press release
Collaboration Aims to Accelerate Adoption of EPR Spectroscopy in Structural Biology and Drug Discovery High Q Technologies, a developer of quantum-enabled electron paramagnetic resonance (EPR) spectroscopy systems, and Creative Biostructure, a structural biology Contract Research Organization, today announced a strategic partnership to support broader adoption of EPR spectroscopy for studying protein dynamics in pharmaceutical and biotechnology research. EPR spectroscopy is increasingly relevant as drug discovery turns toward disordered, flexible, and disease‑relevant protein systems that cannot be fully understood through static structural methods alone. However, broad adoption of EPR has historically been limited by instrument and workflow complexity, and the need for dedicated technical expertise in experimental design and data interpretation. Leveraging quantum sensor technology, FATHOM® EPR has overcome these challenges. By providing unique measurements of long‑range distances, FA
New Tacton Research Reveals Only 7% of Manufacturers Have Achieved End-to-End Value Chain Connectivity2.6.2026 15:00:00 CEST | Press release
Despite growing digital maturity and AI investment, less than half of manufacturers are confident in their ability to deliver effectively on their sales promise to customers. Tacton, a global leader in Configure, Price, Quote (CPQ) solutions for manufacturers of complex, highly configurable products, today released its annual State of Manufacturing report, revealing that rising product complexity is exposing critical cross-functional gaps despite continued investment in digital transformation and AI. Based on a survey of 280 manufacturing leaders in eight countries, the research found that 67% now describe their products as “very” or “extremely” complex, a 20-point increase in just one year. At the same time, only 7% use the same product configuration rules across every team and system involved in selling and building products, which is critical for reducing margin risk because of siloed functions and data. The report highlights a growing industry reality: while digital transformation
HTEC and Xsolis’ Strategic Partnership to Tackle Inefficiencies in Healthcare Decision-Making with AI2.6.2026 14:38:00 CEST | Press release
Collaboration will accelerate the evolution of Xsolis’ Dragonfly platform, improving how healthcare providers and payers make faster, more aligned care decisions HTEC, the global AI-first engineering and digital product development company, today announced a strategic partnership with Xsolis, an AI-driven technology company that reduces administrative waste by enabling collaboration between healthcare providers and payers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260602462348/en/ HTEC, the global AI-first engineering and digital product development company, today announced a strategic partnership with Xsolis, an AI-driven technology company that reduces administrative waste by enabling collaboration between healthcare providers and payers. Across healthcare systems, determining whether a treatment is medically necessary, what level of care a patient requires, and whether that care will be approved remains a slow, manua
Perpetuals Reports $4.5 Billion in UpsideOnly Volume and Signs Exchange Agreement With Datavault AI for Tokenized Commodities2.6.2026 14:00:00 CEST | Press release
UpsideOnly draws more than 30,000 active users from 185 countries in its first two weeksPerpetuals signs exchange agreement with Datavault AI, bringing tokenized gold, copper, geothermal energy, and critical minerals to 24/7 regulated global trading Perpetuals.com Ltd (Nasdaq: PDC) today reported strong early results for its breakout UpsideOnly trading and market prediction platform and announced an agreement with Datavault AI Inc. (Nasdaq: DVLT) to list tokenized real-world commodity assets on the Perpetuals platform. In its first two weeks, traders flocked to the UpsideOnly platform, attracting more than 30,000 active users, generating $4.5 billion in cumulative platform volume across 186,000 fills and 25 instruments. Reflecting the widespread demand for a risk-free product, users came from 185 different countries. Surprisingly, gold was the top instrument with $1.4 billion in volume, outpacing bitcoin at $1.2 billion with precious metals accounting for roughly 35 percent of total pl
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom